Get Permission Sonare and Wackchaure: Treatment of heart failure with low ejection fraction with polyherbs and panchakarma: A case report


Introduction

Heart failure (HF) affects approximately 2% of adults worldwide, a complex clinical syndrome that is a principal cause of early morbidity and mortality,1 Although, advances in medical and instrumental therapy have reduced the mortality rate of patients with chronic heart failure, the first-year mortality rate among hospitalized patients with acute degenerative heart failure is as high as 25%.2

However, the mortality rate of patients developing cardiogenic shock in the setting of acute myocardial infarction has remained unchanged for two decades, even with advances in reperfusion therapy and mechanical circulatory support (MCS).3

Heart failure is classified as a tridoshaja vyadhi in Ayurvedic medicine. Traditional heart failure treatment has improved over the years, yet patient survival and quality of life remain inadequate. Ayurveda treatment as adjuvant therapy in the management of heart failure has been the subject of some published clinical trials. Antioxidant, anti-inflammatory, antiplatelet, and hypolipidemic characteristics are found in many herbal medications. There is a need to assess herbal medicine's potential usefulness in the treatment of heart failure.4, 5 In the present case report, HF was treated for 90 days with conventional medicine and Ayurvedic treatment. Then, only Ayurveda treatment was offered, along with lifestyle adjustment, after examining the cause and risk factors for heart disease.

This case report thereby describes the beneficial role of Ayurveda in heart failure with poor ejection fraction in a 26-year-old female with comorbidities who has been treated in our institute for a year.

Case Report

A 26-year-old female patient reported to Shri vishwakrupa ayurvedalaya and panchkarma Kendra, Warud dist. Amravati with chief complaints of breathlessness, reduced appetite, vertigo, body ache and bilateral feet edema for. month duration. When she presented to our panchkarma center, she had 45.95 kg weight, 98.4 ºf temp. 22RR. her blood pressure was140/90 mm of Hg and pulse was 64 bpm.

Physical examination revealed that, patient had coated tongue and edema in the feet. However, pallor, clubbing and cyanosis were completely absent. Central nervous system (CNS) state was drowsy, (CVS) heart sound was S1 S2 Loud murmur - +, RS – BAEN, PA abdomen was soft, not tender. With sinus rhythm, ECG revealed a left bundle branch block. However, the patient had no previous history of heart failure.

Echocardiography showed systolic and diastolic dysfunction, LVEF of 15 - 20% and a sign of left ventricular hypertrophy (interventricular septal diameter 14 mm, LV posterior wall diameter 12 mm. The enrolled patients was taking Valsartan, Amlodepin, Frusemid, and Digogzin medicines.

Blood investigations

Blood investigations showed normal CBC, PS and KFT. However, more serious condition of heart failure observed, NT-proBNP2 range was 3562.0 pg/ml, (4/1/21) which was higher than normal.

Table below reported, NT-pro BNP level before and after treatment.

Table 1

NT-pro BNP level before and after treatment.

Date of NT-pro BNP

NT-pro BNP

4 Jan 2021

3562.0 pg/mL

4 Jan 2022

220 pg/mL

An echocardiogram test

ECHO test revealed Cardio Myopathy. Below table showed the state of Cardio Myopathy, before and after the treatment.

Table 2

Showing the state of cardio myopathy

Date : 04/01/2021

1.

Cardio Myopathy

2.

Severe Global Hypokinesia

3.

EF of LV= 15 - 20%

4.

Diastolic dysfunction (Grade III)

5.

Mild MR, Mild PH, Trivial TR

6.

Thin Pericardial effusion

7.

IVC Congested

Looking at the above reports, patient was advice for cardiac transplant but due to low economic status so she decided to take Ayurveda treatment.

Differential diagnosis

The closest differential diagnosis in this case could be heart failure due to left ventricular hypertrophy. In this case, the heart failure may also be due to left ventricular hypertrophy, which tightens the wall of the main pumping chamber of the heart. However, the patient also suffers from anemia and diastolic dysfunction. All of these signs indicate that the patient has dilated cardiomyopathy with a low ejection fraction. No further tests were performed after the diagnosis and the patient started receiving Ayurvedic treatment.

Treatment

During this therapy and next 30 days, patient was put on daily routine followed the study dinarcharya and was prescribed healthy diet, ayurvedic medicine, exercise / yoga and panchakarma.

The diet was divided into two meals. The first meal was taken between 9 and 11 in the morning and the last meal was taken in the evening. 6 to 8 p.m. and dietary salt was prohibited. The patient was advised to eat a diet rich in potassium and plenty of fruits. Junk / fast / fermented / heavy oily foods and potatoes, which are high in sodium and fat, were avoided. Patient was advised to do following yoga and light exercises regularly.

Table 0

1.

light stretching,

2.

breathing exercises and cardio breathing

3.

Yogasanas like Bhujangasana, Pavanmuktasana, and Mandukasan (which is suggested to increase the blood flow of the heart.)

5.

Walking on a simple surface for 6 minute walk test (MWT).

6.

5 ml/day of cow urine extract for 21 days.

Patient followed the dinacharya and was also prescribed some polyherbs for the management. Following table (Table 3) enumerate the medications and their specific actions as a treatment modality.

Table 3

Polyherbs and their mechanism of action

Polyherbs

Mechanism of Action

Arjuna-cardiotonic5

Increase heart muscle tone and stroke volume, Vasodilator, improve diastolic dysfunction of heart

Amalki6

Rejuvenation

Brahmi7

Reduction of stress

Vidari Kand / Vidari Kharik

Anabolic action

Guduchi8, Haridra9, Punarnav10 and Hridayarnav juice11, Gokshur12

Additional herbs

Vasant Kusumakar rasa11

Antioxidants, rasadhatu protection

Suvarn sutashekhar rasa

Increase appetite and maintain blood pH.

Shitopaladi churn13

Reduces chest congestion, rejuvenation and also reduce effusion.

Table 4

Steps of panchakarma included in treatment

Sr. no

Panchakarma therapy

1

Snehana/external oleation or massage (30–35 minutes)

This is an external massage technique that uses an oil-based decoction.

2

Swedana/passive heat therapy (10-20 min)

This therapy was administered to HF patients laying supine in a sudation box with the head outside. After that, a steady stream of Dashmoola (a ten-herb group) was passed for 10-15 minutes. Patient was asked to rest for at least one hour after their therapy was over.

3

Basti/medicated enema (~15 min)

Enema drug was administered using rectal solution in the patient. This enema was taken to stay in the body for 15 minutes for maximum absorption. The total administration period was one and a half hours.

4

Hrudaydhara/variation of shirodhara technique (~15 min)

An HF patient's mediastinum was drip-fed with lukewarm Dashmoola decoction from a certain height. It was marked with the help of hrudayapatra.

[i] HF was treated after a light meal or breakfast. The total administration duration was 70-75 minutes.

Outcome and follow-upTable 6

Table 5

Outcomes of ECHO

First ECHO(04/01/2021)

2nd ECHO(30/01/2021)

3rd ECHO (03/01/2022)

Showed cardiomyopathy and Severe global hypokinesia

Mild global hypokinesia as well as mild concentric hypertrophy of the LV

Normal sized chambers and no regional wall movement deformity.

EFLV was of 15 - 20%

EFLV was 35%

EFLV improved by 60%

Diastolic dysfunction (grade III)

Diastolic dysfunction improved to grade(Grade I)

Systolic and diastolic LV

MR and PH were mild and trivial TR was present.

IVC was normal

Normal IVC, Intact atrial and interventricular septum found.

Discussion

Heart failure (HF) remains a major cause of mortality, morbidity, and poor quality of life. It is an area of active research. Heart Failure refers to the heart unable to pump enough oxygenated blood, which is necessary for normal metabolic activity of the body. In addition, high BP, uncontrolled diabetes, valvular heart diseases and ischemic heart disease can also results in myocardial dysfunction resulting in HF.

Since patients suffer from dilated cardiomyopathy, HF is also considered a disabling disease. Dilated cardiomyopathy is significant characteristic that makes HF a disabling disease. "Cardiomyopathy" refers to any abnormal heart muscle condition. Basically, it causes the heart to become enlarged and unable to pump blood efficiently. A dilated cardiomyopathy causes systolic (contractile) dysfunction with normal left ventricular wall thickness and leads to heart failure. Point to ponder in this study is that dilated cardiomyopathy is associated higher risk of mortality. Acharya Charak reported that vitiated agni causes a person to suffer from disease since it disrupts the complete metabolic activity of the body. The Ayurvedic term for cardiac problems is 'Hrudrog'. All causes of heart disease in Ayurveda are dysfunctional rasa dhatvagni, which results in penurious rasa dhaatu reaching the heart, causing various heart conditions. This dhatvagni or bioenergy can be denoted by metabolic rate. MAC can therefore be correlated with rasa dhatvagni. Bioenergy, or rasa dhatvagni, can be expressed through metabolic rate, and MAC can thus be associate with this. The reduction of MAC may result in rasa dhatvagni maandya (reduction in the function of rasa dhatvagni) which resulting in Hrudrog. This is a first follow-up study to report that 7 day HF improves dilated cardiomyopathy with low ejection fraction. Patients with left ventricle low ejection fraction (<30/15 - 20%) and is maintained for 90 days after the therapy. There is a plenty of literature associated to different methods of dilated cardiomyopathy with low ejection fraction estimations. In terms of affordability and convenience, 6 MWT is the most popular test.14

In this complete treatment, we focused on prognosis of vyan vayu (one of the five energy subdivisions of prana) and avalambak cuph, (provide environment for free expansion and relaxation of chest organ), which ultimately improved sadhak pitta. Sadhak pitta is subdosha of Pitta, which resides in the heart. It is responsible for maintained circulation of rhythmic contraction and relaxation of heart. Thereby, miraculously improved values of NT-pro BNP were obtained in the present case after panchkarma as shown in table-1 which suggests the great role that correction of sadhak pita can play patients with heart failure.15

Over the year, Ayurveda is considered the "Mother of All Healing" as it is among the oldest forms of health care. In spite of the fact that considerable scientific research has been done in this area over the last 50 years, the results of these studies have not been adequately propagate.

Therefore, present case report is written with a view to shed light upon the successful outcome of HF patient who was suggested to go for heart transplant procedure with the help of less expensive and less painful ayurveda treatment. To summarize, the treatment tools that were used included different interventions such as exercise, healthy diet, lifestyle modification and polyherbs with panchakarma.

Conclusion

Heart disorders can be caused by rasadhatvagni that lead to the production of poor quality rasadhatu. In the present case, default rasadhatu was reported cause of heart failure with low ejection fraction. In Ayurveda above discussed polyherbs and panchkarma treatment can correct heart function i.e. low ejection fraction.

Patients with HF will benefit from additional cardiac conditioning provided by the herbs used in this case. In the present case, all poly herbs use have shown to improve systolic and diastolic dysfunction. Furthermore, in this case, panchakarma therapies combined with treatment which nourished the body. This case report focuses on the role of ayurvedic treatments in HF patients, and we hope it will be useful to all Ayurvedic and conventional medicine practitioners, students, researchers and the general public. This proves that Ayurveda is a well-established system of medicine which has a significant medical base, and has therapies that can be used alone or in conjunction with conventional health care.

Source of Funding

None.

Conflict of Interest

None.

References

1 

M Metra JR Teerlink Heart failureLancet2017390198195

2 

C Vahdatpour D Collins S Goldberg Cardiogenic ShockJ Am Heart Assoc209088e01199110.1161/JAHA.119.011991

3 

S Rohit M Rahul Efficacy of heart failure reversal treatment in patients with low ejection fractionJ Ayurveda Integr Med2018942859

4 

R Sane A Aklujkar A Patil R Mandole Effect of heart failure reversal treatment as add-on therapy in patients with chronic heart failure: A randomized, open-label studyIndian Heart J2017693299304

5 

K Gauthaman M Saleem TS Ravi V Patel S Niranjali S Devaraj Alcoholic extract of terminalia arjuna protects rabbit heart against ischemic-reperfusion injury: Role of antioxidant enzymes and heat shock proteinWorld Acad Sci Eng Technol20081848898

6 

Ibidem Guduchyadi Bhavaprakasha Varga

7 

V Pandey D Kumar Biofertilizers for Sustainable AgricultureAgric.Today200254447

8 

YB Tripathi S Chaurasia E Tripathi A Upadhyay GP Dubey Bacopa monniera Linn. as an antioxidant: mechanism of actionIndian J Exp Biol1996345236

9 

M Sumanth SS Mustafa Antistress, adoptogenic and immunopotentiating activity roots of Boerhaavia diffusa in miceInt J Pharmacol20073541636

10 

DM Kanchan GS Somani VV Peshattiwar AA Kaikini Sathaye Renoprotective effect of diosgenin in streptozotocin induced diabetic ratsPharmacol Rep20166823707

11 

IK Makhija A Ram HN Shreedhara CS Kumar S Vijay D Raviraj In vitro antioxidant studies of Sitopaladi Churna, a polyherbal Ayurvedic formulation. Free RadAntiox2011123741

12 

S Ghosal VK Tripathi S Chauhan Active constituents of Emblica officinalis, Part I, the chemistry and antioxidant effects of two new hydrolysable tannins, emblicanin A and BIndian J Chem1996359419

13 

S Bhuvad K Nishteswar Assessment of free radical scavenging activity of ten madhuraskandha drugs through UV spectroscopic and chromatographic techniqueJ Pharm Pharm Sci201683926

14 

R M Ross J N Murthy I D Wollak A S Jackson The six minute walk test accurately estimates mean peak oxygen uptakeBMC Pulm Med201010111

15 

A Deb S Barua B Das Pharmacological activities of Baheda (Terminalia bellerica): A reviewJ Pharmacog Phytochem2016511947



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 03-03-2023

Accepted : 27-03-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jpmhh.2023.007


Article Metrics






Article Access statistics

Viewed: 9124

PDF Downloaded: 740